ABC5: Patients with advanced breast cancer are being denied access to life-prolonging drugs
Survival for patients with the most common forms of advanced breast cancer could be substantially…
Browsing: Advanced Breast Cancer Fifth International Consensus Conference
ABC5: Treatment with anti-cancer drug T-DM1 after pertuzumab is ‘good option’
Patients with HER2-positive breast cancer, whose disease has progressed after being treated initially with pertuzumab…
ABC5: Results from largest group of advanced breast cancer patients answers questions about efficacy of T-DM1 when cancer returns following treatment with pertuzumab
Patients with HER2-positive breast cancer, whose disease has progressed after being treated initially with pertuzumab…
ABC5: Giving breast cancer patients an average survival time is more often wrong than right
Doctors who give advanced breast cancer patients just one estimate, such as 12 months, for…
ABC5: Complementary therapies can do more harm than good when breast cancer becomes visible
Patients with advanced breast cancer that has spread to the skin are likely to cause…